373
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Treatment of late bacterial infections resulting from soft-tissue filler injections

, , , , , & show all
Pages 469-480 | Published online: 20 Feb 2019

References

  • PlasticSurgery.org [website on the Internet]American Society of Plastic Surgeons Online Resources, Inc2017Plastic Surgery Statistics Report Available from: https://edition.cnn.com/2017/12/21/health/dermal-lip-filler-injections-risks-study/index.htmlAccessed December 18, 2018
  • RequenaLRequenaCChristensenLZimmermannUSKutznerHCerroniLAdverse reactions to injectable soft tissue fillersJ Am Acad Dermatol201164113421167403
  • AlhedeMBjarnsholtTAre biofilms responsible for the adverse effects experienced following soft-tissue fillers?Future Microbiol20149893193325302951
  • ChristensenLBreitingVJanssenMVuustJHogdallEAdverse reactions to injectable soft tissue permanent fillersAesthetic Plast Surg2005291344815759096
  • BjarnsholtTTolker-NielsenTGivskovMJanssenMChristensenLHDetection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesionsDermatol Surg200935Suppl 21620162419709133
  • SaththianathanMJohaniKTaylorAThe role of bacterial biofilm in adverse soft-tissue filler reactions: a combined laboratory and clinical studyPlast Reconstr Surg2017139361362128234833
  • AlhedeMErÖEickhardtSBacterial biofilm formation and treatment in soft tissue fillersPathog Dis201470333934624482426
  • DayanSArkinsJBrindiseRSoft tissue fillers and biofilmsFacial plast Surg2011271232821246453
  • HøibyNBjarnsholtTMoserCESCMID guideline for the diagnosis and treatment of biofilm infections 2014Clin Microbiol Infect201521Suppl 1S1S2525596784
  • Hall-StoodleyLStoodleyPKathjuSTowards diagnostic guidelines for biofilm-associated infectionsFEMS Immunol Med Microbiol201265212714522469292
  • SinghSSinghSKChowdhuryISinghRUnderstanding the mechanism of bacterial biofilms resistance to antimicrobial agentsOpen Microbiol J2017111536228553416
  • HøibyNBjarnsholtTGivskovMMolinSCiofuOAntibiotic resistance of bacterial biofilmsInt J Antimicrob Agents201035432233220149602
  • CiofuORojo-MolineroEMaciàMDOliverAAntibiotic treatment of biofilm infectionsAPMIS2017125430431928407419
  • AndrePFléchetMLAngioedema after ovine hyaluronidase injection for treating hyaluronic acid overcorrectionJ Cosmet Dermatol20087213613818482018
  • CavalliniMGazzolaRMetallaMVaientiLThe role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillersAesthet Surg J20133381167117424197934
  • MenonHThomasMD’SilvaJLow dose of hyaluronidase to treat over correction by HA filler – a case reportJ Plast Reconstr Aesthet Surg2010634e416e41720133216
  • CohenBeBasheySWysongAThe use of hyaluronidase in cosmetic dermatology: a review of the literatureJ Clin Investigat Dermatol2015327
  • Parra-RuizJVidaillacCRoseWERybakMJActivities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilmAntimicrob Agents Chemother201054104329433420696880
  • JacquelineCCaillonJImpact of bacterial biofilm on the treatment of prosthetic joint infectionsJ Antimicrob Chemother201469Suppl 1i37i4025135088
  • San JuanRGarcia-ReyneACabaPSafety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infectionsAntimicrob Agents Chemother201054125161516620855727
  • SwidsinskiADörffelYLoening-BauckeVSchillingJMendlingWResponse of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatmentFEMS Immunol Med Microbiol2011611414620955467
  • GuayDRMoxifloxacin in the treatment of skin and skin structure infectionsTher Clin Risk Manag20062441743418360653
  • FujimuraSSatoTHayakawaSKawamuraMFurukawaEWatanabeAAntimicrobial efficacy of combined clarithromycin plus daptomycin against biofilms-formed methicillin-resistant Staphylococcus aureus on titanium medical devicesJ Infect Chemother2015211075675926162777
  • FujimuraSSatoTMikamiTKikuchiTGomiKWatanabeACombined efficacy of clarithromycin plus cefazolin or vancomycin against Staphylococcus aureus biofilms formed on titanium medical devicesInt J Antimicrob Agents200832648148418790609
  • GanderSKinnairdAFinchRTelavancin: in vitro activity against staphylococci in a biofilm modelJ Antimicrob Chemother200556233734315972312
  • ElkhatibWNoreddinAEfficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental modelMicrob Drug Resist201420657558225050970
  • HouWXiaoHThe eliminating effects of clarithromycin combined with ciprofloxacin on Pseudomonas aeruginosa biofilms in the middle ear mucosa of ratsInt J Clin Exp Med20169229452952
  • NetsvyetayevaIMaruszaWOlszanskiRSkin bacterial flora as a potential risk factor predisposing to late bacterial infection after cross-linked hyaluronic acid gel augmentationInfect Drug Resist20181121322229483779
  • MaruszaWMlynarczykGOlszanskiRProbable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16Int J Nanomedicine201271441144722619504